Thibault Boutherin
Stock Analyst at Morgan Stanley
(3.62)
# 2,165
Out of 5,082 analysts
145
Total ratings
62.2%
Success rate
6.4%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVS Novartis AG | Maintained: Buy | $156 → $163 | $156.86 | +3.91% | 5 | Oct 28, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 650.00 | CHF 635.80 | +2.23% | 11 | Oct 14, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Sell | CHF 50.00 → CHF 60.00 | CHF 82.10 | -26.92% | 5 | Oct 6, 2026 | |
| NVO Novo Nordisk | Downgraded: Sell | $40 | $38.67 | +3.44% | 6 | Sep 11, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Buy | CHF 135.00 | CHF 128.78 | +4.83% | 14 | Sep 1, 2026 | |
| SWX: GALD Galderma Group AG | Reiterated: Hold | CHF 155.00 → CHF 160.00 | CHF 185.00 | -13.51% | 9 | Apr 27, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €40.00 → €53.00 | €46.15 | +14.84% | 5 | Mar 11, 2026 | |
| BME: GRF Grifols, S.A. | Downgraded: Hold | €12.00 → €11.00 | €10.66 | +3.24% | 7 | Mar 10, 2026 | |
| ALVO Alvotech | Reiterated: Buy | $14 → $10 | $4.75 | +110.53% | 4 | Dec 3, 2025 | |
| ETR: MRK Merck KGaA | Reiterated: Hold | €130.00 → €135.00 | €144.50 | -6.57% | 5 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $36 | $34.72 | +3.69% | 11 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €300.00 | €290.70 | n/a | 3 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €250.00 | €221.80 | n/a | 3 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 2,100p → 2,400p | 1,704p | n/a | 15 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €12.00 | €2.88 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 | $1.57 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €120.00 | €152.50 | n/a | 18 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $39 | $99.36 | n/a | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | CHF 4.00 → CHF 1.00 | CHF 4.55 | n/a | 11 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $8.10 | n/a | 4 | Dec 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €11.50 → €11.00 | €10.44 | n/a | 5 | Nov 13, 2023 |
Novartis AG
Oct 28, 2026
Maintained: Buy
Price Target: $156 → $163
Current: $156.86
Upside: +3.91%
Lonza Group AG
Oct 14, 2026
Reiterated: Buy
Price Target: CHF 650.00
Current: CHF 635.80
Upside: +2.23%
Sandoz Group AG
Oct 6, 2026
Reiterated: Sell
Price Target: CHF 50.00 → CHF 60.00
Current: CHF 82.10
Upside: -26.92%
Novo Nordisk
Sep 11, 2026
Downgraded: Sell
Price Target: $40
Current: $38.67
Upside: +3.44%
Novartis AG
Sep 1, 2026
Reiterated: Buy
Price Target: CHF 135.00
Current: CHF 128.78
Upside: +4.83%
Galderma Group AG
Apr 27, 2026
Reiterated: Hold
Price Target: CHF 155.00 → CHF 160.00
Current: CHF 185.00
Upside: -13.51%
Bayer Aktiengesellschaft
Mar 11, 2026
Reiterated: Buy
Price Target: €40.00 → €53.00
Current: €46.15
Upside: +14.84%
Grifols, S.A.
Mar 10, 2026
Downgraded: Hold
Price Target: €12.00 → €11.00
Current: €10.66
Upside: +3.24%
Alvotech
Dec 3, 2025
Reiterated: Buy
Price Target: $14 → $10
Current: $4.75
Upside: +110.53%
Merck KGaA
Dec 3, 2025
Reiterated: Hold
Price Target: €130.00 → €135.00
Current: €144.50
Upside: -6.57%
Dec 3, 2025
Reiterated: Buy
Price Target: $28 → $36
Current: $34.72
Upside: +3.69%
Apr 22, 2025
Reiterated: Buy
Price Target: €300.00
Current: €290.70
Upside: n/a
Apr 22, 2025
Reiterated: Buy
Price Target: €250.00
Current: €221.80
Upside: n/a
Feb 12, 2025
Reiterated: Hold
Price Target: 2,100p → 2,400p
Current: 1,704p
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: €12.00
Current: €2.88
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: $13
Current: $1.57
Upside: n/a
May 15, 2024
Reiterated: Hold
Price Target: €120.00
Current: €152.50
Upside: n/a
May 8, 2024
Reiterated: Hold
Price Target: $36 → $39
Current: $99.36
Upside: n/a
Apr 3, 2024
Reiterated: Sell
Price Target: CHF 4.00 → CHF 1.00
Current: CHF 4.55
Upside: n/a
Dec 29, 2023
Reiterated: Hold
Price Target: $16
Current: $8.10
Upside: n/a
Nov 13, 2023
Reiterated: Hold
Price Target: €11.50 → €11.00
Current: €10.44
Upside: n/a